A military-funded biosensor could be the future of pandemic detection

In the future of healthcare technology, it is applicable. Why are pandemics so hard to stop? Often because the disease moves faster than people can get tested. The Department of Defense is helping fund a new study to determine if a biosensor under the skin can help trackers keep on detecting flu-like infections even before their symptoms begin to appear. Its manufacturer, Profusa, says the sensor is on its way to attempting FDA approval early next year.

The sensor has two parts. One is a 3mm hydrogel chain, a material whose network of polymer chains is used in some contact lenses and other implants. Inserted under the skin with a syringe, the cord includes a specially affected molecule that changes color when the body begins to fight an infection. The other part is an electronic component attached to the skin. It sends light through the skin, detects if it produces a color change and generates a signal that the user can send to a doctor, website, etc. It is like a laboratory of blood in the skin that can detect the body's response to the disease before the presence of other symptoms, such as cough.

future of health technology


The announcement comes when the United States deals with COVID-19, a respiratory illness that can occur in symptoms similar to the complaint, such as cough and shortness of breath. The army is taking a leading role in vaccine research, said the president of the Joint Chiefs of Staff, General Mark Milley, a journalist at the Pentagon. “Our military research laboratories are working feverishly around the horn here to try to invent a vaccine. So we'll see how that develops in the coming months, "Milley said. American troops are also at risk. A US soldier in South Korea will become the first member of the US service to contract the virus, Wall Street Magazine reported. in February.

The last study funded by Profusa. Because the gel doesn't actually emit any signal, it doesn't reveal a soldier's position, so the sensor could have sensitive problems like behind enemy lines, Profusa CEO Ben Hwang said.

Hwang said his company received grants from the Defense Advanced Research Projects Agency, or DARPA, since around 2011. "They gave us grant money to help our investigation and, a measure that demonstrates a certain milestone, a measure that we eliminate the risk of technology, they say a second sentence and a third phase and provide support, "he said:" Your support has gone from grants to such programs that create real-world evidence. "

Hwang said DARPA is helping the company communicate with other teams within the Department of Defense that it could use the device on troops or service members. That could include partnerships with the US Special Operations Command. UU., For example, or the Indo-Pacific Command. He declined to comment on talks with specific military clients

Post a Comment

0 Comments